Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [619]

OncoAlert Colloquium Day 2: Lung cancer and MASCC

Dr Stephen Liu, Dr Jack West, Dr Sanay Popat, Dr Jarushka Naidoo, Dr Percy Lee...

OncoAlert Colloquium Day 2: Lung cancer and MASCC ( Dr Stephen Liu, Dr Jack West, Dr Sanay Popat, Dr Jarushka Naidoo, Dr Percy Lee, Ms Jill Feldman, Ms Ivy Elkins, Dr Andrew Davies & Dr Joanne Bowen )

OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology

Dr Toni Choueiri, Dr Andrea Apolo, Dr Neeraj Agarwal, Dr Piet Ost, Dr Sean...

OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology ( Dr Toni Choueiri, Dr Andrea Apolo, Dr Neeraj Agarwal, Dr Piet Ost, Dr Sean McBride, Dr Ravindran Kanesvaran & Dr Nicolo Battisti )

The RxPONDER trial and its impact on best clinical practice

Prof Christos Markopoulos and Prof Giuseppe Curigliano

The RxPONDER trial and its impact on best clinical practice ( Prof Christos Markopoulos and Prof Giuseppe Curigliano )

Advances in prostate cancer in the last 10 years and a glimpse to the future

Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono

Advances in prostate cancer in the last 10 years and a glimpse to the future ( Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono )

OncoAlert and ecancer weekly round up for October 11th - October 16, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for October 11th - October 16, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

ESMO 2021: Updates in hormone-sensitive prostate cancer

Prof Eleni Efstathiou, Prof Axel Merseburger, Prof Nicolas Mottet, Dr Elena...

ESMO 2021: Updates in hormone-sensitive prostate cancer ( Prof Eleni Efstathiou, Prof Axel Merseburger, Prof Nicolas Mottet, Dr Elena Castro )

Enzalutamide plus androgen deprivation therapy prolongs survival in men with...

Prof Andrew Armstrong - Duke University, Durham, USA

Enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-sensitive prostate cancer ( Prof Andrew Armstrong - Duke University, Durham, USA )

Adding abiraterone acetate plus prednisolone to standard therapy lengthens...

Prof Nick James - The Institute of Cancer Research, London, UK

Adding abiraterone acetate plus prednisolone to standard therapy lengthens survival in non-metastatic high-risk prostate cancer ( Prof Nick James - The Institute of Cancer Research, London, UK )

OncoAlert and ecancer - ESMO 2021 Day 5

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer - ESMO 2021 Day 5 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

OncoAlert and ecancer - ESMO 2021 Day 3

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer - ESMO 2021 Day 3 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

First-line CDK 4/6 inhibition shows OS benefit for metastatic breast cancer

Prof Gabriel Hortobagyi - The University of Texas MD Anderson Cancer Center...

First-line CDK 4/6 inhibition shows OS benefit for metastatic breast cancer ( Prof Gabriel Hortobagyi - The University of Texas MD Anderson Cancer Center, Houston, Texas )

OncoAlert and ecancer - ESMO 2021 Day 2

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer - ESMO 2021 Day 2 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

More from ecancer